Search results for "gene-editing"

showing 2 items of 2 documents

Deploying Genome Editing Tools for Dissecting the Biology of Nut Trees

2019

Walnuts are among the most important nut crops grown in temperate regions of the world. Commercial production in California, and increasingly worldwide, relies on only few clonally grafted scion genotypes, particularly “Chandler,” and more recently clonally propagated disease-resistant rootstocks. Diseases, nematodes, insect pests, abiotic stresses, and other nutritional and environmental factors, can reduce walnut productivity and quality, affecting grower profitability. The California Walnut Breeding Program at UC Davis has developed and released scion cultivars and rootstocks to help address some of these problems. Sequencing of the walnut genome is expected to speed walnut breeding by f…

Phytoene desaturaseCRISPR-Cas9; gene-editing; gRNA; nut crops; oxidative stress; phytoene desaturase; plastid healthBreeding programnut cropgRNAgene-editinglcsh:TX341-641HorticultureManagement Monitoring Policy and LawBiologyGenomeCropGenome editingSettore AGR/07 - Genetica Agrariaoxidative stressGlobal and Planetary Changeoxidative strelcsh:TP368-456Ecologybusiness.industryfungifood and beveragesPhenotypic traitBiotechnologySettore AGR/03 - Arboricoltura Generale E Coltivazioni Arboreelcsh:Food processing and manufacturephytoene desaturaseplastid healthCRISPR-Cas9nut cropsRootstockbusinesslcsh:Nutrition. Foods and food supplyAgronomy and Crop ScienceHickory nutFood Science
researchProduct

New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia.

2021

: Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder. The most common cause is a mutation in both alleles of the gene encoding for the low-density lipoprotein (LDL) receptor, although other causative mutations have been identified. Complications of atherosclerotic cardiovascular disease are common in these patients; therefore, reducing the elevated LDL-cholesterol burden is critical in their management. Conventionally, this is achieved by patients initiating lipid-lowering therapy, but this can present challenges in clinical practice. Fortunately, novel therapeutic strategies have enabled promising innovations in HoFH treatment. This review highlights recent and ongo…

Settore MED/09 - Medicina InternaGenetic enhancementHomozygous familial hypercholesterolemiaFamilial hypercholesterolemiaInclisiranBioinformaticsmedicine.disease_causeBenzimidazolePCSK9Hyperlipoproteinemia Type IIchemistry.chemical_compoundGene therapyAnticholesteremic AgentmedicineAngiopoietin-like 3HumansLow-density lipoprotein cholesterolAlleleAngiopoietin-like 3; Gene therapy; Gene-editing; Homozygous familial hypercholesterolemia; Inclisiran; Lomitapide; Low-density lipoprotein cholesterol; PCSK9MutationGene-editingAtherosclerotic cardiovascular diseasebusiness.industryPCSK9Anticholesteremic AgentsHomozygoteGenetic disorderGeneral MedicineCholesterol LDLmedicine.diseaseLomitapideLomitapidechemistrylipids (amino acids peptides and proteins)BenzimidazolesCardiology and Cardiovascular MedicinebusinessHumanHeart failure clinics
researchProduct